Torigen Pharmaceuticals

Torigen is a biopharmaceutical company focused on the development of novel cancer therapies and therapeutics for inflammatory disease. As a team of veterinarians and cancer researchers, we are focused on creating novel and accessible therapies to the veterinary market. Our first product, an autologous cancer immunotherapy, is created from a surgically resected portion of tumor that is submitted to our lab. Once at our lab, we can submit to histopathology, and if it is a malignancy, we are able to leave the option of immunotherapy open to the veterinarian and pet owner.